Clinical characteristics of 182 pediatric COVID‐19 patients with different severities and allergic status
Open Access
- 3 September 2020
- Vol. 76 (2), 510-532
- https://doi.org/10.1111/all.14452
Abstract
Background The pandemic of coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has made widespread impact recently. We aim to investigate the clinical characteristics of COVID‐19 children with different severities and allergic status. Methods Data extracted from the electronical medical records, including demographics, clinical manifestations, comorbidities, laboratory and immunological results and radiological images of 182 hospitalized COVID‐19 children were summarized and analyzed. Results The median age was 6 years old, ranging from 3 days to 15 years, and there were more boys (male‐female ratio about 2:1) within the studied 182 patients. Most of the children were infected by family members. Fever (43.4%) and dry cough (44.5%) were common symptoms, and gastrointestinal manifestations accounted for 11.0%, including diarrhea, abdominal discomfort and vomiting. 71.4% had abnormal chest computed tomography (CT) scan images, and typical signs of pneumonia were ground‐glass opacity and local patchy shadowing on admission. Laboratory results were mostly within normal ranges, and only a small ratio of lymphopenia (3.9%) and eosinopenia (29.5%) were observed. The majority (97.8%) of infected children were not severe, and 24 (13.2%) of them had asymptomatic infections. Compared to children without pneumonia(manifested as asymptomatic and acute upper respiratory infection), children with pneumonia were associated with higher percentages of the comorbidity history, symptoms of fever and cough, and increased levels of serum procalcitonin, alkaline phosphatase and serum interleukins (IL)‐2, IL‐4, IL‐6, IL‐10 and TNF‐α.There were no differences of treatments, duration of hospitalization, time from first positive to first negative nucleic acid testing and outcomes between children with mild pneumonia and without pneumonia. All the hospitalized COVID‐19 children had recovered except one death due to intussusception and sepsis. In 43 allergic children with COVID‐19, allergic rhinitis (83.7%) was the major disease, followed by drug allergy, atopic dermatitis, food allergy and asthma. Demographics and clinical features were not significantly different between allergic and non‐allergic groups. Allergic patients showed less increase in acute phase reactants, procalcitonin, D‐dimer and aspartate aminotransferase levels compared to all patients. Immunological profiles including circulating T, B and NK lymphocyte subsets, total immunoglobulin and complement levels and serum cytokines did not show any difference in allergic and pneumonia groups. Neither eosinophil counts nor serum total immunoglobulin E (IgE) levels showed a significant correlation with other immunological measures, such as other immunoglobulins, complements, lymphocyte subsets numbers and serum cytokine levels. Conclusion Pediatric COVID‐19 patients tended to have a mild clinical course. Patients with pneumonia had higher proportion of fever and cough and increased inflammatory biomarkers than those without pneumonia. There was no difference between allergic and non‐allergic COVID‐19 children in disease incidence, clinical features, laboratory and immunological findings. Allergy was not a risk factor for developing and severity of SARS‐CoV‐2 infection and hardly influenced the disease course of COVID‐19 in children.Keywords
This publication has 47 references indexed in Scilit:
- Does atopy affect the course of viral pneumonia?Allergologia et Immunopathologia, 2018
- Pediatric allergy and immunology in ChinaPediatric Allergy and Immunology, 2017
- Update on Human Rhinovirus and Coronavirus InfectionsSeminars in Respiratory and Critical Care Medicine, 2016
- Obesity is a risk factor for allergic rhinitis in children of Wuhan (China)Asia Pacific Allergy, 2016
- Trends in allergy prevalence among children aged 0–17 years by asthma status, United States, 2001–2013Journal of Asthma, 2016
- The first wheezing episode: respiratory virus etiology, atopic characteristics, and illness severityPediatric Allergy and Immunology, 2014
- Diagnosis, management, and prognosis of preschool wheezeThe Lancet, 2014
- Allergic diseases and asthma: a global public health concern and a call to actionWorld Allergy Organization Journal, 2014
- [Third nationwide survey of childhood asthma in urban areas of China].2013
- Viruses and bacteria in acute asthma exacerbations – A GA2LEN‐DARE* systematic reviewAllergy, 2010